- Targeted screening intervention to increase detection
- The use of Xpert MTB RIF in diagnosing pulmonary and extra pulmonary TB
- The revised definitions and treatment regimen for retreatment patients
- Management of adverse drug events
- ART initiation and follow-up of patients on both ART and TB medicines
Over the last eight years, Treatment Action Group (TAG) has tracked annual spending on tuberculosis research and development (TB R&D) and compared investments in six areas of research with the corresponding annual funding targets called for by the Stop TB Partnership’s 2011–2015 Global Plan to Stop TB (2011–2015 Global Plan). For the first seven years, TAG observed slow and unsteady increases in funding signaling slow progress toward the new tools needed to end the global TB epidemic. This year, for the first time, TB R&D investors reported a drop in spending that threatens to undermine the tenuous gains made since 2005.
The urgency of the problem of TB in children, whose full scope is still not fully known, cannot be underestimated. World Health Organization (WHO) estimates in 2012 revealed that up to 74 000 children die from TB each year and children account for around half a million new cases annually. It should be noted that the estimated deaths only include those in human immunodeficiency virus (HIV)-negative children. In fact, the actual burden of TB in children is likely higher, especially given the challenge in diagnosing childhood TB. Compounding this difficulty with diagnosis is the fact that children with TB often come from families that are poor, lack knowledge about the disease and live in communities with limited access to health services.
Complete a Report on Mortality Amongst Clients Initiating TB Treatment in the Ventersdorp Sub-District of North West Province
Poverty has long been recognized as one of the factors predisposing people to TB (Lancet 2005) and, in South Africa, many patients with TB live in poor conditions. In order to ameliorate these conditions, a few initiatives to support patients with TB have been made in KwaZulu-Natal. To date, support for TB patients has been provided in the form of free treatment at government hospitals and clinics (Department of Health 2001), and nutritional supplementation and social grants (Department of Social Development 2006)1.
The implementation of the National Tuberculosis Control Programme (NTCP) at a regional/district hospital and three of its feeder clinics: A Case Study
The purpose of this study was to identify and understand the health system constraints to providing effective care to patients with tuberculosis (TB) in a combined regional/district hospital and three of its feeder clinics in an area with a high incidence of TB and high prevalence of HIV. The study was funded by the National Department of Health.